JTR  Vol.5 No.1 , March 2017
A Comparative Study of Drug Susceptibility Testing Techniques for Identification of Drug Resistant TB in a Tertiary Care Centre, South India
Abstract: India tops the global list for Drug resistant Tuberculosis, but inadequate and expensive laboratory culture techniques have led to delay in the diagnosis and treatment. We studied the potential of an alternative method which could be cost-effective by combining the drugs in the same tube for identification of drug resistance. Drug Susceptibility Test (DST) results of 1000 sputum samples are got from suspected TB patients against INH (isoniazid) and Rifampicin by two techniques: a) a modified technique with both drugs in the same MGIT tube and b) a standard technique with the antibiotics in separate MGIT tubes for the diagnosis of MDR-TB (Multidrug Resistant). 39 samples were contaminated and were excluded from final analysis. 198 were smear positives by the concentrated Ziehl-Neelsen’s staining method. 219 were found to be culture positive out of which 195 were identified as M. tuberculosis complex. 40 (20.5%) strains were identified as MDR-TB by the conventional method and 39 were picked up by the modified DST. INH and Rifampicin mono-resistance accounted for 32 (16.4%) and 4 (2%) respectively. 99% concordance was observed between the two tests in categorizing MDR-TB. Similarly modified technique with combination of the second line Antibiotics-Ofloxacin, Kanamycin and Capreomycin was applied on the identified MDR strains in a stepwise manner. 6 (15%) were identified as Pre-XDR strains and 2 (5%) were found to be XDR-TB strains. This study implies that combining drugs in the same tube may be an equivalent and possibly a cost-effective alternative which needs to be explored further.
Cite this paper: Kumar, J. , Srinivasa, H. and Chiramal, J. (2017) A Comparative Study of Drug Susceptibility Testing Techniques for Identification of Drug Resistant TB in a Tertiary Care Centre, South India. Journal of Tuberculosis Research, 5, 44-57. doi: 10.4236/jtr.2017.51005.

[1]   World Health Organization (2015) Global Tuberculosis Report 2015. WHO.

[2]   Central TB Division (2015) TB India 2015. Annual Status Report.

[3]   CDC (2006) Emergence of Mycobacterium tuberculosis with Extensive Resistance to Second-Line Drugs—Worldwide, 2000-2004. Morbidity and Mortality Weekly Report, 55, 301-305.

[4]   Kim, D.H., Kim, H.J., Park, S.-K., Kong, S.-J., Kim, Y.S., Kim, T.-H., et al. (2010) Treatment Outcomes and Survival Based on Drug Resistance Patterns in Multidrug-Resistant Tuberculosis. American Journal of Respiratory and Critical Care Medicine, 182, 113-119.

[5]   World Health Organization (2015) Guidelines for Surveillance of Drug Resistance in Tuberculosis. 5th Edition, World Health Organization, Geneva, 76 p.

[6]   World Health Organization (2015) Tuberculosis (Mdr-Tb) Factsheet.

[7]   Olson, S., English, R.A., Guenther, R.S. and Claiborne, A.B. (2012) Facing the Reality of Drug-Resistant Tuberculosis in India.

[8]   Michael, J.S. and John, T.J. (2012) Extensively Drug-Resistant Tuberculosis in India: A Review. Indian Journal of Medical Research, 136, 599-604.

[9]   Yadav, R.N., Singh, B.K., Sharma, S.K., Sharma, R., Soneja, M., Sreenivas, V., et al. (2013) Comparative Evaluation of GenoType MTBDRplus Line Probe Assay with Solid Culture Method in Early Diagnosis of Multidrug Resistant Tuberculosis (MDR-TB) at a Tertiary Care Centre in India. PLoS ONE, 8, e72036.

[10]   Limaye, K., Kanade, S., Nataraj, G. and Mehta, P. (2010) Utility of Microscopic Observation of Drug Susceptibility (MODS) Assay for Mycobacterium tuberculosis in Resource Constrained Settings. Indian Journal of Tuberculosis, 57, 207-212.

[11]   Barnard, M., Gey Van Pittius, N.C., Van Helden, P.D., Bosman, M., Coetzee, G. and Warren, R.M. (2012) The Diagnostic Performance of the GenoType MTBDRplus Version 2 Line Probe Assay Is Equivalent to that of the Xpert MTB/RIF Assay. Journal of Clinical Microbiology, 50, 3712-3716.

[12]   World Health Organization (2007) Use of Liquid TB Culture and Drug Susceptibility Testing (DST) in Low and Medium Income Settings. Policy Statement.

[13]   Stop TB Partnership (2014) Mycobacteriology Laboratory Manual. 51-66.

[14]   Jesuraj, A., Kumar, U. and Srinivasa, H. (2015) Fast and Accurate Identification of M. tuberculosis Complex Using an Immunochromatographic MPT64 Antigen Detection Test. Journal of Tuberculosis Research, 3, 149-156.

[15]   Zhao, L.L., Xia, Q., Lin, N., Liu, B., Zhao, X.Q., Liu, Z., et al. (2012) Evaluation of BACTEC MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis in China. Journal of Microbiological Methods, 91, 212-214.

[16]   Kim, H., Seo, M., Park, Y.K., Yoo, J.I., Lee, Y.S., Chung, G.T., et al. (2013) Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis. Tuberculosis Respiratory Treatment, 2013, Article ID: 108401.

[17]   Boum, Y., Orikiriza, P., Rojas-Ponce, G., Riera-Montes, M., Atwine, D., Nansumba, M., et al. (2013) Use of Colorimetric Culture Methods for Detection of Mycobacterium tuberculosis Complex Isolates from Sputum Samples in Resource-Limited Settings. Journal of Clinical Microbiology, 51, 2273-2279.

[18]   Chang, C.L., Park, T.S., Oh, S.H., Kim, H.H., Lee, E.Y., Son, H.C., et al. (2002) Reduction of Contamination of Mycobacterial Growth Indicator Tubes with a Modified Antimicrobial Combination. Journal of Clinical Microbiology, 40, 3845-3847.

[19]   Ruddy, M., McHugh, T.D., Dale, J.W., Banerjee, D., Maguire, H., Wilson, P., et al. (2002) Estimation of the Rate of Unrecognized Cross-Contamination with Mycobacterium tuberculosis in London Microbiology Laboratories. Journal of Clinical Microbiology, 40, 4100-4104.

[20]   Raveendran, R., Oberoi, J.K. and Wattal, C. (2015) Multidrug-Resistant Pulmonary & Extrapulmonary Tuberculosis: A 13 Years Retrospective Hospital-Based Analysis. Indian Journal of Medical Research, 142, 575-582.

[21]   Levidiotou, S., Papamichael, D., Gessouli, E., Golegou, S., Anagnostou, S., Galana- kis, E., et al. (1999) Detection of Mycobacteria in Clinical Specimen Using the Mycobacteria Growth Indicator Tube (MGIT) and the Lowenstein Jensen Medium. Microbiological Research, 154, 151-155.

[22]   Porwal, C., Kaushik, A., Makkar, N., Banavaliker, J.N., Hanif, M., Singla, R., et al. (2013) Incidence and Risk Factors for Extensively Drug-Resistant Tuberculosis in Delhi Region. PLoS ONE, 8, 1-7.

[23]   James, P., Gupta, R., Christopher, D.J., Thankagunam, B. and Veeraraghavan, B. (2011) MDR- and XDR-TB among Suspected Drug-Resistant TB Patients in a Tertiary Care Hospital in India. Clinical Respiratory Journal, 5, 19-25.

[24]   Balaji, V., Daley, .P, Anand, A.A., Sudarsanam, T., Michael, J.S., Sahni, R.D., et al. (2010) Risk Factors for MDR and XDR-TB in a Tertiary Referral Hospital in India. PLoS ONE, 5, e9527.

[25]   Udwadia, Z. and Moharil, G. (2014) Multidrug-Resistant-Tuberculosis Treatment in the Indian Private Sector: Results from a Tertiary Referral Private Hospital in Mumbai. Lung India, 31, 336-341.